Recent News

• 06.04.2025 - Vigil Neuroscience Provides Update on Iluzanebart Phase 2 IGNITE Trial in ALSP
• 06.04.2025 - Vigil Neuroscience Provides Update on Iluzanebart Phase 2 IGNITE Trial in ALSP
• 05.21.2025 - Vigil Neuroscience Enters into Definitive Merger Agreement to be Acquired by Sanofi
• 05.21.2025 - Vigil Neuroscience Enters into Definitive Merger Agreement to be Acquired by Sanofi

Recent Filings

• 05.30.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 05.27.2025 - SCHEDULE 13D/A General Statement of Acquisition of Beneficial Ownership
• 05.23.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.23.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.23.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.23.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.23.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.23.2025 - 8-K Current report
• 05.23.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.23.2025 - 4 Statement of changes in beneficial ownership of securities